Pharmaceuticals
Global Impact of Covid-19 coronavirus on “non-Covid” clinical trials
12 June 2020 - Posted by: Zara Sproul
In recent weeks and months, the life sciences sector has been the focal point of efforts to respond to the Covid-19 threat. While these efforts have – justifiably – occupied many of the headlines, this blog post looks at the impact of the pandemic on “non-Covid” focused clinical trials and steps taken to limit disruption › Read More
France – Update of national early meetings guide for medicines evaluation
11 June 2020 - Posted by: Jeanne Fabre
On 29 April 2020, the French High Health Authority (HAS) updated its guide on national early meetings for medicines evaluation. As part of its action plan for innovative medicines and its work programme presented at the beginning of 2020, the HAS has revised its guide to early meetings which aims to support businesses in the › Read More
Belgium – Covid-19 coronavirus: measures affecting the life sciences sector
10 June 2020 - Posted by: Tine Carmeliet
In the fight against the Covid-19 coronavirus pandemic, the Belgium government has taken several exceptional measures, including (i) restricting the sale of certain medical devices and personal protective equipment; (ii) issuing a Guideline for the reuse of surgical masks and FFP2/FFP3 masks; and (iii) communicating on how Covid-19 tests should be made available in Belgium. › Read More
09 June 2020 - Posted by: Jeanne Fabre
Further to publishing evaluation criteria for serological tests for antibodies against SARS-CoV-2 (available here), the French High Health Authority (HAS) published on 18 May 2020 its opinion on the use of rapid serological tests (including self-tests) and an educational paper on Covid-19 coronavirus serological tests. The HAS indicated that while all serological tests used for › Read More
Start of French medical cannabis pilot programme postponed to January 2021
03 June 2020 - Posted by: Eveline Van Keymeulen
Today, the French Medicines Agency (ANSM) and the Health Ministry published an update on the continuance of the work of the Scientific Committee (CST) with respect to the French medical cannabis pilot programme. The update confirms that, following the activities carried out since 2018, the Directorate General for Health (DGS) and the ANSM remain fully › Read More